Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
8.71
0.00 (0.05%)
At close: Aug 8, 2025, 4:00 PM
8.31
-0.40 (-4.64%)
After-hours: Aug 8, 2025, 7:37 PM EDT
GNOM Holdings Information
GNOM is an equity ETF with a total of 49 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 6.88%, Avidity Biosciences at 5.93%, CRISPR Therapeutics AG at 5.56%, Illumina at 4.80%, and Qiagen at 4.37%.
Total Holdings
49
Top 10 Percentage
47.33%
Asset Class
Equity
ETF Category
Health
Assets
43.74M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.88% |
| 2 | RNA | Avidity Biosciences, Inc. | 5.93% |
| 3 | CRSP | CRISPR Therapeutics AG | 5.56% |
| 4 | ILMN | Illumina, Inc. | 4.80% |
| 5 | QGEN | Qiagen N.V. | 4.37% |
| 6 | GH | Guardant Health, Inc. | 4.23% |
| 7 | LEGN | Legend Biotech Corporation | 4.18% |
| 8 | MRNA | Moderna, Inc. | 3.84% |
| 9 | TECH | Bio-Techne Corporation | 3.83% |
| 10 | BNTX | BioNTech SE | 3.71% |
| 11 | BMRN | BioMarin Pharmaceutical Inc. | 3.67% |
| 12 | NTRA | Natera, Inc. | 3.64% |
| 13 | WGS | GeneDx Holdings Corp. | 3.31% |
| 14 | HKG: 1548 | Genscript Biotech Corporation | 3.06% |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 2.92% |
| 16 | RARE | Ultragenyx Pharmaceutical Inc. | 2.85% |
| 17 | VCYT | Veracyte, Inc. | 2.67% |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.30% |
| 19 | A | Agilent Technologies, Inc. | 2.08% |
| 20 | LON: AZN | AstraZeneca PLC | 2.04% |
| 21 | GILD | Gilead Sciences, Inc. | 1.98% |
| 22 | BEAM | Beam Therapeutics Inc. | 1.92% |
| 23 | BMY | Bristol-Myers Squibb Company | 1.79% |
| 24 | TWST | Twist Bioscience Corporation | 1.77% |
| 25 | TXG | 10x Genomics, Inc. | 1.63% |
As of Aug 7, 2025